← Evidence map

TrialNeurology2010

Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.

E L Logigian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

60 papers cite it

2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

NCT01406873phase 242 enrolled2011
Full record →Abstract, authors, funding and every citing paper · PMID 20439846